SB Krantz

4.1k total citations · 1 hit paper
43 papers, 3.4k citations indexed

About

SB Krantz is a scholar working on Hematology, Physiology and Genetics. According to data from OpenAlex, SB Krantz has authored 43 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 31 papers in Physiology and 14 papers in Genetics. Recurrent topics in SB Krantz's work include Erythrocyte Function and Pathophysiology (31 papers), Erythropoietin and Anemia Treatment (17 papers) and Blood groups and transfusion (14 papers). SB Krantz is often cited by papers focused on Erythrocyte Function and Pathophysiology (31 papers), Erythropoietin and Anemia Treatment (17 papers) and Blood groups and transfusion (14 papers). SB Krantz collaborates with scholars based in United States, Australia and Japan. SB Krantz's co-authors include Robert T. Means, EN Dessypris, MC Bondurant, Chunhua Dai, Amittha Wickrema, R S Stein, JC Winkelmann, K Sawada, ST Sawyer and Clark Da and has published in prestigious journals such as Blood and PubMed.

In The Last Decade

SB Krantz

43 papers receiving 3.2k citations

Hit Papers

Erythropoietin 1991 2026 2002 2014 1991 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
SB Krantz United States 24 2.2k 1.0k 1.0k 673 516 43 3.4k
DG Nathan United States 33 2.5k 1.1× 1.4k 1.4× 730 0.7× 493 0.7× 732 1.4× 101 4.0k
Sanford B. Krantz United States 42 3.3k 1.5× 2.1k 2.1× 1.7k 1.7× 1.5k 2.3× 1.0k 2.0× 123 5.8k
K Sawada Japan 25 1.1k 0.5× 571 0.6× 490 0.5× 497 0.7× 552 1.1× 60 2.4k
Harvey R. Gralnick United States 35 2.0k 0.9× 689 0.7× 213 0.2× 560 0.8× 432 0.8× 92 3.8k
Bruce M. Ewenstein United States 49 4.7k 2.2× 1.5k 1.5× 281 0.3× 1.3k 1.9× 889 1.7× 149 6.9k
F L Johnson United States 30 2.7k 1.2× 719 0.7× 163 0.2× 427 0.6× 749 1.5× 60 4.0k
H Rochant France 26 978 0.4× 452 0.4× 390 0.4× 604 0.9× 336 0.7× 107 1.9k
Andrew M. Yeager United States 30 2.8k 1.3× 805 0.8× 254 0.2× 996 1.5× 689 1.3× 91 4.5k
Paul Friese United States 22 1.4k 0.6× 334 0.3× 169 0.2× 487 0.7× 770 1.5× 35 2.6k
Georges E. Rivard Canada 29 1.8k 0.8× 394 0.4× 225 0.2× 705 1.0× 153 0.3× 70 2.9k

Countries citing papers authored by SB Krantz

Since Specialization
Citations

This map shows the geographic impact of SB Krantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SB Krantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SB Krantz more than expected).

Fields of papers citing papers by SB Krantz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SB Krantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SB Krantz. The network helps show where SB Krantz may publish in the future.

Co-authorship network of co-authors of SB Krantz

This figure shows the co-authorship network connecting the top 25 collaborators of SB Krantz. A scholar is included among the top collaborators of SB Krantz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SB Krantz. SB Krantz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wickrema, Amittha, et al.. (1994). Erythroid-specific processing of human beta spectrin I pre-mRNA. Blood. 84(6). 1992–1999. 25 indexed citations
3.
Wickrema, Amittha, SB Krantz, JC Winkelmann, & MC Bondurant. (1992). Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells [see comments]. Blood. 80(8). 1940–1949. 120 indexed citations
5.
Means, Robert T. & SB Krantz. (1992). Progress in understanding the pathogenesis of the anemia of chronic disease [see comments]. Blood. 80(7). 1639–1647. 479 indexed citations
6.
Wickrema, Amittha, SB Krantz, JC Winkelmann, & MC Bondurant. (1992). Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells [see comments]. Blood. 80(8). 1940–1949. 98 indexed citations
8.
9.
Krantz, SB. (1991). Erythropoietin. Blood. 77(3). 419–434. 7 indexed citations
10.
Dai, Chunhua, SB Krantz, & KM Zsebo. (1991). Human burst-forming units-erythroid need direct interaction with stem cell factor for further development. Blood. 78(10). 2493–2497. 9 indexed citations
11.
Krantz, SB, et al.. (1990). Growth of highly purified human CFU-E in serum-free medium.. PubMed. 352. 9–20. 3 indexed citations
12.
Sawyer, ST, SB Krantz, & K Sawada. (1989). Receptors for erythropoietin in mouse and human erythroid cells and placenta. Blood. 74(1). 103–109. 74 indexed citations
14.
Krantz, SB, et al.. (1987). Specific binding of erythropoietin to human erythroid colony-forming cells.. PubMed. 100. 164–72. 4 indexed citations
15.
Dessypris, EN, et al.. (1985). Diphenylhydantoin-induced pure red cell aplasia. Blood. 65(4). 789–794. 46 indexed citations
16.
Dessypris, EN, et al.. (1984). Acquired immune hemolytic anemia associated with IgA erythrocyte coating: investigation of hemolytic mechanisms. Blood. 64(5). 1000–1005. 30 indexed citations
17.
Da, Clark, EN Dessypris, & SB Krantz. (1984). Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients. Blood. 63(2). 277–286. 86 indexed citations
19.
Dessypris, EN, et al.. (1982). Mode of action of the IgG inhibitor of erythropoiesis in transient erythroblastopenia of children. Blood. 59(1). 114–123. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026